Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Drug for treating coronary heart disease

A technology of coronary heart disease and medicine, applied in the field of medicine for the treatment of coronary heart disease, can solve the problems of myocardial no-reflow, remodeling, etc., achieve the effect of less side effects, good curative effect, and improve the level of new drug creation and international competitiveness

Inactive Publication Date: 2013-12-04
王新程
View PDF0 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Although modern medicine has made significant progress in pharmaceutical intervention and interventional therapy, many clinical problems remain unsolved, such as myocardial no-reflow after reperfusion, ventricular remodeling after myocardial infarction, etc.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0014] Embodiment 1: A kind of medicament for treating coronary heart disease, described medicament comprises following component:

[0015] 30g Astragalus, 40g Angelica, 30g Caulis Spatholobus, 40g Chinese Cabbage Root, 40g Vernaceae, 30g Radix Radix Puerariae, 30g Pueraria Root, 40g Peach Branch, 40g Polygala, 40g Tinglizi, 40g Peach Kernel, 30g Platycodon grandiflorum, 30g Chuanxiong, 30g Salvia miltiorrhiza, Allium 30g, Buxus 30g, Panax notoginseng 40g, Toosendan 40g, Aconitum 40g, Morinda officinalis 30g, Cinnabar 30g, Duhuo 30g, Aconite 30g.

Embodiment 2

[0016] Embodiment 2: a kind of medicament for treating coronary heart disease, described medicament comprises following component:

[0017] 20g Astragalus, 35g Angelica, 20g Caulis Spatholobus, 35g Chinese cabbage root, 35g Rhizoma chinensis, 20g Ophiopogon japonicus, 20g Pueraria root, 35g peach branch, 35g polygala, 35g Tinglizi, 35g peach kernel, 20g bellflower, 20g Chuanxiong, 20g salvia miltiorrhiza, Allium 20g, Buxus 20g, Panax notoginseng 35g, Toosendan 35g, Wuyao 35g, Morinda officinalis 20g, Cinnabar 20g, Duhuo 20g, Aconite 20g.

Embodiment 3

[0018] Embodiment 3: a kind of medicament for treating coronary heart disease, described medicament comprises following component:

[0019] 40g Astragalus, 45g Angelica, 40g Caulis Spatholobus, 45g Chinese Cabbage Root, 45g Herba Vermilione, 40g Radix Radix Puerariae, 40g Pueraria Root, 45g Peach Branch, 45g Polygala, 45g Tinglizi, 45g Peach Kernel, 40g Bellflower, 40g Chuanxiong, 40g Salvia, Allium 40g, Buxus 40g, Panax notoginseng 45g, Toosendan 45g, Wuyao 45g, Morinda officinalis 40g, Cinnabar 40g, Duhuo 40g, Aconite 40g.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a drug for treating coronary heart disease. The drug is characterized by comprising the following components: 20-40 g membranous milkvetch root, 35-45 g Chinese angelica, 20-40 g suberect spatholobus stem, 35-45 g Chinese cabbage root, 35-45 g potentilla discolor, 20-40 g dwarf lilyturf turber, 20-40 g kudzuvine root and the like. The invention provides a traditional Chinese medicine for treating coronary heart disease, which is excellent in curative effect and less in side effects, can be manufactured into tablets, powder and other compound Chinese herbal preparations as required by adopting conventional methods. The invention builds a technical platform for innovative traditional Chinese medicine research and development in the aspects of safety, drug effect evaluation, pharmacodynamics, pharmacokinetics and the like of compound traditional Chinese medicines, and can further improve the new medicine creation level and international competitiveness in China.

Description

technical field [0001] The invention relates to the field of traditional Chinese medicine, in particular to a medicament for treating coronary heart disease. Background technique [0002] Coronary heart disease is a major disease that seriously threatens human health and life. Its morbidity and mortality are increasing year by year, which has brought a heavy medical burden to the society. It is a major public health problem in our country. Therefore, the prevention and treatment of coronary heart disease is very important. important. Although modern medicine has made significant progress in pharmaceutical intervention and interventional therapy, many clinical problems remain unsolved, such as myocardial no-reflow after reperfusion and ventricular remodeling after myocardial infarction. Traditional Chinese medicine has many therapeutic principles and clinical effectiveness, such as replenishing qi and activating blood circulation, removing blood stasis and promoting regenera...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/8968A61P9/10A61K33/28
Inventor 王新程
Owner 王新程
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products